Changes in Thyroid Function Parameters during Short-Term LowConcentration Povidone–Iodine Gargling in Young Adults with Asymptomatic SARS-CoV-2 Infection: A Single-Arm Prospective Cohort Study

Singh et al., International Journal of Drug Delivery Technology, doi:10.25258/ijddt.16.46s.21, Jun 2026

PVP-I for COVID-19

14th treatment shown to reduce risk in February 2021, now with p = 0.0000000037 from 21 studies.

No treatment is 100% effective.
Protocols combine treatments.

Prospective study of 45 young adults with asymptomatic SARS-CoV-2 infection showing no clinically significant thyroid dysfunction with short-term low-concentration povidone-iodine gargling.
Singh et al., 4 Jun 2026, prospective, India, peer-reviewed, 4 authors, study period April 2020 - May 2020. Contact: jbsingh1@gmail.com (corresponding author), jbsingh1@gmail.com (corresponding author), jbsingh1@gmail.com (corresponding author), jbsingh1@gmail.com (corresponding author), shibusasi@gmail.com, manoj.congo@gmail.com, vishnuprasath2@gmail.com.
Abstract: ## RESEARCH PAPER Changes in Thyroid Function Parameters during Short-Term LowConcentration Povidone-Iodine Gargling in Young Adults with Asymptomatic SARS-CoV-2 Infection: A Single-Arm Prospective Cohort Study Jung Bahadur Singh 1* , Shibu Sasidharan 1 , Manoj Kumar Sharma 1 , Vishnuprasad R 2 1 Department of Anaesthesiology, Critical Care and Emergency Medicine, Base Hospital Delhi Cantonment, Delhi, India. 2 Specialist Community Medicine, Military Hospital, Jammu. Email addresses: JBS - jbsingh1@gmail.com SS - shibusasi@gmail.com MKS - manoj.congo@gmail.com VR - vishnuprasath2@gmail.com *Corresponding author: Dr Jung Bahadur Singh, Department of Anaesthesiology, Critical Care and Emergency Medicine, Base Hospital Delhi Cantonment, Delhi, India. Email: jbsingh1@gmail.com Abstract Background. Povidone-iodine (PVP-I) gargles were widely recommended as an oropharyngeal antiseptic measure during the COVID-19 pandemic on the basis of in vitro virucidal activity against SARS-CoV-2. Repeated oral exposure to iodine-containing solutions raises theoretical concerns regarding systemic iodine absorption and thyroid homeostasis, including the Wolff-Chaikoff inhibitory effect and iodine-induced thyrotoxicosis. Empirical data on thyroid biochemistry during short-term, low-concentration PVP-I gargling in adults concurrently infected with SARS-CoV-2 are limited. Objectives. To describe changes in serum free triiodothyronine (fT3), total thyroxine (TT4), and thyroid-stimulating hormone (TSH) in young euthyroid adults with asymptomatic SARS-CoV-2 infection during a standardised regimen of short-term, low-concentration PVP-I gargling, without inferring causality. Methods. In this single-arm, single-centre, prospective cohort study conducted at a tertiary care hospital in Leh, Ladakh (April-May 2020), 45 inpatients aged 20-35 years with reverse transcription polymerase chain reaction (RT-PCR)confirmed, clinically asymptomatic SARS-CoV-2 infection and a normal baseline thyroid profile gargled once daily with 15 mL of 0.33% PVP-I solution (approximately 5 mg of available iodine per gargle) for 30 seconds at bedtime under direct nursing observation. Gargling continued until the first negative SARS-CoV-2 RT-PCR (10-15 days). Serum fT3, TT4, and TSH were measured at enrolment (Time A) and at first negative RT-PCR (Time B) on a single electrochemiluminescence immunoassay platform; paired samples from each participant were stored at -20 °C and processed in the same analytical run. Distributional normality was assessed by the Shapiro-Wilk test; paired comparisons used the paired t-test with Wilcoxon signed-rank as a sensitivity analysis. Standardised within-subject effect sizes (Cohen's dz) and Bonferroni-adjusted p-values were reported. A pre-specified sensitivity analysis stratified participants by exposure duration (≤ 12 vs > 12 days). Results. Mean serum fT3 rose from 3.21 ± 0.46 pg/mL at Time A to 3.30 ± 0.45 pg/mL at Time B (mean change Time B - Time A = +0.09 pg/mL; 95% CI 0.073 to 0.105; dz = 1.80; p < 0.001; Bonferroni-adjusted p < 0.003). Mean serum TT4 rose from 7.97 ± 1.63 to 8.02 ± 1.62 µg/dL (mean change +0.05 µg/dL; 95% CI 0.020 to 0.074; dz = 0.56; adjusted p = 0.003). Serum TSH did not change significantly (2.54 ± 0.88 vs. 2.60 ± 1.19 µIU/mL; mean change +0.06 µIU/mL; 95% CI -0.27 to 0.38; dz = 0.06; p = 0.721). All thyroid parameters remained..
DOI record: { "DOI": "10.25258/ijddt.16.46s.21", "ISSN": [ "0975-4415" ], "URL": "http://dx.doi.org/10.25258/ijddt.16.46s.21", "abstract": "<jats:p>Background. Povidone–iodine (PVP–I) gargles were widely recommended as an oropharyngeal antiseptic measure\nduring the COVID-19 pandemic on the basis of in vitro virucidal activity against SARS-CoV-2. Repeated oral exposure\nto iodine-containing solutions raises theoretical concerns regarding systemic iodine absorption and thyroid homeostasis,\nincluding the Wolff–Chaikoff inhibitory effect and iodine-induced thyrotoxicosis. Empirical data on thyroid biochemistry\nduring short-term, low-concentration PVP–I gargling in adults concurrently infected with SARS-CoV-2 are limited.\nObjectives. To describe changes in serum free triiodothyronine (fT3), total thyroxine (TT4), and thyroid-stimulating\nhormone (TSH) in young euthyroid adults with asymptomatic SARS-CoV-2 infection during a standardised regimen of\nshort-term, low-concentration PVP–I gargling, without inferring causality.\nMethods. In this single-arm, single-centre, prospective cohort study conducted at a tertiary care hospital in Leh, Ladakh\n(April–May 2020), 45 inpatients aged 20–35 years with reverse transcription polymerase chain reaction (RT-PCR)–\nconfirmed, clinically asymptomatic SARS-CoV-2 infection and a normal baseline thyroid profile gargled once daily with\n15 mL of 0.33% PVP–I solution (approximately 5 mg of available iodine per gargle) for 30 seconds at bedtime under\ndirect nursing observation. Gargling continued until the first negative SARS-CoV-2 RT-PCR (10–15 days). Serum fT3,\nTT4, and TSH were measured at enrolment (Time A) and at first negative RT-PCR (Time B) on a single\nelectrochemiluminescence immunoassay platform; paired samples from each participant were stored at −20 °C and\nprocessed in the same analytical run. Distributional normality was assessed by the Shapiro–Wilk test; paired comparisons\nused the paired t-test with Wilcoxon signed-rank as a sensitivity analysis. Standardised within-subject effect sizes\n(Cohen's dz) and Bonferroni-adjusted p-values were reported. A pre-specified sensitivity analysis stratified participants\nby exposure duration (≤ 12 vs &gt; 12 days).\nResults. Mean serum fT3 rose from 3.21 ± 0.46 pg/mL at Time A to 3.30 ± 0.45 pg/mL at Time B (mean change Time B\n− Time A = +0.09 pg/mL; 95% CI 0.073 to 0.105; dz = 1.80; p &lt; 0.001; Bonferroni-adjusted p &lt; 0.003). Mean serum TT4\nrose from 7.97 ± 1.63 to 8.02 ± 1.62 µg/dL (mean change +0.05 µg/dL; 95% CI 0.020 to 0.074; dz = 0.56; adjusted p =\n0.003). Serum TSH did not change significantly (2.54 ± 0.88 vs. 2.60 ± 1.19 µIU/mL; mean change +0.06 µIU/mL; 95%\nCI −0.27 to 0.38; dz = 0.06; p = 0.721). All thyroid parameters remained within laboratory reference ranges, and no\nparticipant developed clinical thyroid dysfunction or local adverse effects. The observed directional pattern — a small\nrise in fT3 and TT4 with stable TSH — is not the suppressive signature classically predicted under an acute iodine load,\nand is compatible with non-iodine influences including recovery from low-T3 non-thyroidal illness syndrome during\nclearance of acute SARS-CoV-2 infection.\nConclusion. In this single-arm cohort without a non-exposed comparator, thyroid hormone trajectories during short-term,\nlow-concentration PVP–I gargling in young euthyroid adults with asymptomatic SARS-CoV-2 infection remained within\nthe laboratory reference range and showed no biochemical signature of acute iodine-induced thyroid inhibition. These\nfindings are compatible with — but cannot prove — the short-term thyroid safety of dilute PVP–I gargling; controlled\nstudies incorporating urinary iodine quantification and a non-exposed comparator are required for causal attribution.</jats:p>", "author": [ { "affiliation": [ { "name": "Department of Anaesthesiology, Critical Care and Emergency Medicine, Base Hospital Delhi Cantonment, Delhi, India" } ], "family": "Singh", "given": "Jung Bahadur", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "first" }, { "affiliation": [ { "name": "Department of Anaesthesiology, Critical Care and Emergency Medicine, Base Hospital Delhi Cantonment, Delhi, India" } ], "family": "Sasidharan", "given": "Shibu", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Department of Anaesthesiology, Critical Care and Emergency Medicine, Base Hospital Delhi Cantonment, Delhi, India" } ], "family": "Sharma", "given": "Manoj Kumar", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Specialist Community Medicine, Military Hospital, Jammu" } ], "family": "R", "given": "Vishnuprasad", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" } ], "container-title": "International Journal of Drug Delivery Technology", "container-title-short": "IJDDT", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2026, 6, 4 ] ], "date-time": "2026-06-04T09:32:16Z", "timestamp": 1780565536000 }, "deposited": { "date-parts": [ [ 2026, 6, 4 ] ], "date-time": "2026-06-04T09:32:17Z", "timestamp": 1780565537000 }, "indexed": { "date-parts": [ [ 2026, 6, 4 ] ], "date-time": "2026-06-04T10:04:33Z", "timestamp": 1780567473573, "version": "3.54.1" }, "is-referenced-by-count": 0, "issue": "46s", "issued": { "date-parts": [ [ 2026, 6, 4 ] ] }, "journal-issue": { "issue": "46s", "published-online": { "date-parts": [ [ 2026, 6, 4 ] ] } }, "link": [ { "URL": "https://impactfactor.org/PDF/IJDDT/16/IJDDT,Vol16,Issue46s,Article21.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "10897", "original-title": [], "prefix": "10.25258", "published": { "date-parts": [ [ 2026, 6, 4 ] ] }, "published-online": { "date-parts": [ [ 2026, 6, 4 ] ] }, "publisher": "Dr. Yashwant Research Labs Pvt. Ltd.", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "https://impactfactor.org/PDF/IJDDT/16/IJDDT,Vol16,Issue46s,Article21.pdf" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Changes in Thyroid Function Parameters during Short-Term LowConcentration Povidone–Iodine Gargling in Young Adults with Asymptomatic SARS-CoV-2 Infection: A Single-Arm Prospective Cohort Study", "type": "journal-article", "volume": "16" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit